Antitrust & Competition Policy Blog

Editor: D. Daniel Sokol
University of Florida
Levin College of Law

A Member of the Law Professor Blogs Network

Friday, August 31, 2012

Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case

Posted by D. Daniel Sokol

Daniela Ampollini (Trevisan & Cuonzo) is Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case.

ABSTRACT: The January 2012 decision of the Italian Antitrust Authority ("IAA") in the Pfizer case, involving Pfizer's actions to counter the marketing of generic versions of its product Xalatan, has given rise to a debate which has hardly appeased. Many commentators have already provided their impression from a competition law perspective. I, a patent lawyer, will try to provide mine, starting from the meaning and function of the patent law categories involved.

http://lawprofessors.typepad.com/antitrustprof_blog/2012/08/looking-for-sense-in-the-italian-antitrust-authority-decision-in-the-pfizer-xalatan-case.html

| Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef016768f925bd970b

Listed below are links to weblogs that reference Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case:

Comments

Post a comment